[Management of the extravasation of antineoplastic agents]

Boulanger J, l'Institut national d'excellence en santé et en services sociaux, Comité de l'évolution des pratiques en oncologie et du sous-comité dédié aux guides et aux conseils, Comité de l'évolution de la pratique des soins pharmaceutiques à la Direction québécoise de cancérologie, du ministère de la Santé et des Services sociaux
Record ID 32014000663
French
Authors' recommendations: Extravasation is a potentially serious complication that can occur during the administration of chemotherapy. There is little evidence for developing an optimal management scheme. This clinical guideline was prepared by the Comité de l'évolution des pratiques en oncologie (CEPO) in cooperation with the guideline and advice subcommittee of the Comité de l'évolution de la pratique des soins pharmaceutiques of the Ministère de la Santé et des Services sociaux's Direction québécoise de cancérologie. The objective was to examine the relevant scientific literature on the management and treatment of extravasation that occurs when chemotherapy is administered to cancer patients. Given the evidence available at this time and the guidelines published by various organizations, the CEPO makes some recommandations.
Details
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Antineoplastic Agents
Contact
Organisation Name: Institut national d'excellence en sante et en services sociaux
Contact Address: L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name: demande@inesss.qc.ca
Contact Email: demande@inesss.qc.ca
Copyright: ©Gouvernement du Québec/Institut national d'excellence en santé et en services sociaux
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.